Posted in CollabRx News, Publications, Targeted Therapy Finder, Targeting Cancer by Jeff Shrager on February 22, 2012 | No Comments »
A team including leading lung cancer researchers, and CollabRx scientists, has just published a novel Lung Cancer Molecular Disease Model in PLoS ONE, a leading peer-reviewed open source journal. (click here to read the published paper online). This is the model that underlies the CollabRx Lung Cancer Targeted Therapy Finder App.
Posted in Cancer News, CollabRx News, Publications, Targeted Therapy Finder, Targeting Cancer by Ben Kaplan on February 16, 2012 | No Comments »
February, 2012 — CollabRx’s Lung Cancer Targeted Therapy Finder and Dr. Ravi Salga, chief editor and advisor for the Lung Cancer Targeted Therapy Finder, are featured in an article published by the University of Chicago School of Medicine as part of their Comprehensive Cancer Center’s lung cancer program.
Posted in CollabRx News, Publications, Targeted Therapy Finder by Jeff Shrager on November 18, 2011 | No Comments »
An article appearing in the Nov. 2, 2011 issue of Genome Web highlights the CollabRx Targeted Therapy Finders in the context of a discussion about the complexities of pre-screening regarding clinical trials for personalized (targeted) therapies. continue reading
Posted in CollabRx News, Targeted Therapy Finder by Ben Kaplan on November 9, 2011 | No Comments »
– Healthcare and Pharma Veteran James Karis joins as company expands its “app”-centric approach to new cancers
PALO ALTO, Calif.–(BUSINESS WIRE)–CollabRx, the company that leverages information technology to inform personalized cancer treatment planning, announces the release of a Targeted Therapy Finder application (“app”) for lung cancer. Targeted Therapy Finder apps are dynamically updated online resources that enable physicians and patients to identify diagnostic tests and clinical trials associated with therapies that “target” the unique genetic profiles of patients’ tumors. The Targeted Therapy Finder – Lung Cancer app builds on the success of the first such app released by CollabRx earlier this year for melanoma. The melanoma app was created in partnership with the American Society of Clinical Oncology (ASCO) as a first-of-its kind resource for cancer patients and physicians. continue reading
Posted in Events, Videos by Ben Kaplan on October 26, 2011 | No Comments »
Dr. Marty Tenenbaum, Chairman and co-Founder of CollabRx recently spoke at the Open Science Summit 2011 about Open Medicine and Clinical Trials 2.0. Dr. Tenenbaum described the concept of an open community that compiles and continually refines information about cancer subtypes and treatments based on actual patient outcomes.